There is an update mid Jan that expands a little on their oncology results - that qualifies in my opinion but I'm sure there will be more in the next newsletter or, even better would be a price sensitive ASX announcement of internal research! I will still be looking over the next 3 months for new collaborations, agreements that were hatched at the JPM conference 2 weeks ago. I assume if there was anything worth dealing it,would take a couple of months to hatch the details so Feb might be too early but Mar/Apr/May would be prime time.
There is an update mid Jan that expands a little on their...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
0.000(0.00%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.28 | $11.03M | 8.523M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9192 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 6719 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |